Michael S. Kobor

May 2, 2024 | erj.ersjournals.com | Julie L. MacIsaac |Michael S. Kobor |Jean Bourbeau |Don D. Sin

To the Editor:Cannabis use has been controversial, largely having been designated a controlled substance over the past century. While certain studies have linked cannabis smoking with harmful effects such as increased respiratory symptoms and faster lung function decline in older adults [1, 2], these findings have not been fully replicated by others [3]. The link between cannabis and disease pathogenesis may best be explored through DNA methylation.

May 2, 2024 | erj.ersjournals.com | Julie L. MacIsaac |Michael S. Kobor |Jean Bourbeau |Don D. Sin

To the Editor:Cannabis use has been controversial, largely having been designated a controlled substance over the past century. While certain studies have linked cannabis smoking with harmful effects such as increased respiratory symptoms and faster lung function decline in older adults [1, 2], these findings have not been fully replicated by others [3]. The link between cannabis and disease pathogenesis may best be explored through DNA methylation.

Apr 12, 2024 | erj.ersjournals.com | Julia L. MacIsaac |Michael S. Kobor |Jean Bourbeau |Don D. Sin

FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article. Conflicts of Interests: None reported by any of the authors.